主酶PDK1在瘤发生中的作用
Nana Zheng1, Jiaqi Wei1, Depei Wu1
1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
3-氨基酸依赖蛋白激酶1 (PDK1) 是一种调节细胞生长和存活的主激酶. 它的失调和过度表达与癌症有关,使PDK1成为一个有前途的治疗标.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 3-酸依赖蛋白激酶1 (PDK1) 是AGC激酶家族的一个关键调节剂.
- PDK1活动由自酸化和上游调节者 (如S6K和SPOP) 控制.
- PDK1在细胞生长,转移,入侵,亡和存活中发挥着关键作用.
研究的目的:
- 综合审查PDK1在癌症中的上游调节器,下游信号和治疗潜力.
- 突出PDK1在调节瘤微环境和影响癌症免疫疗法的作用.
主要方法:
- 文献综述和对PDK1.1现有研究的综合.
- 分析PDK1在各种癌症类型中的作用及其治疗影响.
主要成果:
- 在许多癌症中观察到PDK1过度表达.
- 抑制PDK1可以减少瘤生长,细胞大小和进展.
- PDK1影响瘤微环境,并影响癌症免疫治疗结果.
结论:
- PDK1是癌症发展和进展的关键因素.
- 向PDK1为各种癌症提供了一个有前途的治疗策略.
- 对PDK1抑制剂及其临床应用的进一步研究是有必要的.
更多相关视频
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
